Another blood pressure medication recalled over carcinogen concerns

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

EAST WINDSOR, N.J. – Another blood pressure medication has been recalled over concerns it could contain trace amounts of carcinogens.

The medication is manufactured by Aurobindo Pharma USA, Inc. The recall is voluntary.

It affects 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP.

If you take the drug, contact your doctor.

You can check out all the latest drug recalls here.

Six blood pressure medications have been recalled since November.

All have been found to have trace amounts of N-nitrosodiethylamine (NDEA) and are manufactured by different companies.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.